Early Intensive vs a Delayed Conservative Simvastatin Strategy in Patients With Acute Coronary Syndromes
James A. de Lemos, Michael A. Blazing(The University of Texas Southwestern Medical Center), Stephen D. Wiviott(The University of Texas Southwestern Medical Center), Eldrin F. Lewis(The University of Texas Southwestern Medical Center), Keith A.A. Fox(The University of Texas Southwestern Medical Center), Harvey D. White(The University of Texas Southwestern Medical Center), Jean‐Lucien Rouleau(The University of Texas Southwestern Medical Center), Terje R. Pedersen(The University of Texas Southwestern Medical Center), Laura H. Gardner(The University of Texas Southwestern Medical Center), Robin Mukherjee(The University of Texas Southwestern Medical Center), Karen E. Ramsey(The University of Texas Southwestern Medical Center), Joanne Palmisano(The University of Texas Southwestern Medical Center), David W. Bilheimer(The University of Texas Southwestern Medical Center), Marc A. Pfeffer(The University of Texas Southwestern Medical Center), Robert M. Califf(The University of Texas Southwestern Medical Center), Eugene Braunwald(The University of Texas Southwestern Medical Center), for the ASTEROID Investigators
Cited by 1,330
Abstract
2][3] More recently, 2 ran-domized controlled trials have evaluated earlier initiation of statin therapy following an ACS event and have noted a corresponding early reduction in major cardiovascular events. 5,
Related Papers
No related papers found
Powered by citation graph analysis